Literature DB >> 35475108

Opsoclonus-Myoclonus in a Patient With Japanese Encephalitis: A Video-Based Case.

Kumar Saurabh1, Reyaz Ahmad1.   

Abstract

Japanese encephalitis is one of the most important causes of viral encephalitis in Asian countries caused by an arbovirus belonging to the flavivirus family. Complications following infection are frequent. Most common complications include dystonia, movement disorders, seizures, behavioral abnormalities, and persistent cognitive impairment. Herein, we describe a patient who after one month of being diagnosed with Japanese encephalitis developed opsoclonus-myoclonus. At a two-month follow-up, opsoclonus-myoclonus significantly improved with steroid therapy.
Copyright © 2022, Saurabh et al.

Entities:  

Keywords:  japanese encephalitis; opsoclonus-myoclonus; paraneoplastic; post-infectious; self-limiting

Year:  2022        PMID: 35475108      PMCID: PMC9034973          DOI: 10.7759/cureus.23469

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  18 in total

1.  Anterior horn cells are also involved in Japanese encephalitis.

Authors:  U K Misra; J Kalita
Journal:  Acta Neurol Scand       Date:  1997-08       Impact factor: 3.209

Review 2.  An update on opsoclonus.

Authors:  Agnes Wong
Journal:  Curr Opin Neurol       Date:  2007-02       Impact factor: 5.710

3.  MRI in Japanese encephalitis.

Authors:  S Kumar; U K Misra; J Kalita; V Salwani; R K Gupta; R Gujral
Journal:  Neuroradiology       Date:  1997-03       Impact factor: 2.804

4.  Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus.

Authors:  L Bataller; F Graus; A Saiz; J J Vilchez
Journal:  Brain       Date:  2001-02       Impact factor: 13.501

5.  Japanese encephalitis (JE). Part I: clinical profile of 1,282 adult acute cases of four epidemics.

Authors:  N B S Sarkari; A K Thacker; S P Barthwal; V K Mishra; Shiv Prapann; Deepak Srivastava; M Sarkari
Journal:  J Neurol       Date:  2011-06-17       Impact factor: 4.849

6.  Seizures in Japanese encephalitis.

Authors:  U K Misra; J Kalita
Journal:  J Neurol Sci       Date:  2001-09-15       Impact factor: 3.181

7.  Therapeutic down-regulation of central and peripheral B-cell-activating factor (BAFF) production in pediatric opsoclonus-myoclonus syndrome.

Authors:  Michael R Pranzatelli; Elizabeth D Tate; Erik R Hoefgen; Jennifer A Swan; Jerry A Colliver
Journal:  Cytokine       Date:  2008-08-09       Impact factor: 3.861

8.  Pediatric opsoclonus-myoclonus-ataxia syndrome: Experience from a tertiary care university hospital.

Authors:  Akshata Huddar; Parayil S Bindu; Madhu Nagappa; Rose D Bharath; Sanjib Sinha; Pavagada S Mathuranath; Arun B Taly
Journal:  Neurol India       Date:  2018 Sep-Oct       Impact factor: 2.117

9.  Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial.

Authors:  Pedro A de Alarcon; Katherine K Matthay; Wendy B London; Arlene Naranjo; Sheena C Tenney; Jessica A Panzer; Michael D Hogarty; Julie R Park; John M Maris; Susan L Cohn
Journal:  Lancet Child Adolesc Health       Date:  2017-11-03

10.  Opsoclonus myoclonus syndrome in a patient with Japanese encephalitis: a case report.

Authors:  Subatharshini Sountharalingam; H M M T B Herath; Dharshana Wijegunasinghe; Sunethra Senanayke
Journal:  J Med Case Rep       Date:  2017-10-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.